Sigrid Stabiliser contains SiPore®, a patented mesoporous silica technology developed at Stockholm University by Professor Tore Bengtsson. Each daily portion of 4 capsules provides 1500 mg of silicon dioxide (E551) as SiPore® micron-sized particles with engineered pores.The SiPore® technology has been studied in clinical trials including the STAR trial (open-label, single-arm, 12 weeks, 9 g/day, n=43) and the SHINE trial (randomized, double-blind, placebo-controlled, 12 weeks, 9 g/day, n=318) using gel formulations of SiPore at higher doses. The capsule formulation provides a lower daily dose (1,5 g) than the doses used in those trials.The product is taken with main meals together with a full glass of water. SiPore® particles are not absorbed and pass through the digestive system intact. Suitable for vegan and vegetarian diets (HPMC vegetable capsule).Consider using a Continuous Glucose Monitor (CGM) to evaluate individual response. Consult a healthcare practitioner before use if you have diabetes, take medication for blood glucose control, have gastrointestinal disease, or are pregnant or breastfeeding.
